C. Bellon et al., LONG-TERM PROGNOSIS OF SUSTAINED VENTRICU LAR-TACHYCARDIA, Archives des maladies du coeur et des vaisseaux, 88(7), 1995, pp. 1013-1019
The authors anlysed the clinical and paraclinical variables of 116 pat
ients admitted the Hopital Cardiologique de Lyon between 1986 and 1990
with sustained ventricular tachycardia without cardocirculatory arres
t in order to determine the long-term outcome and the prognostic facto
rs of death and recurrence. The average age of the patients was 56 +/-
15 years (mean =/- SD) and 83% were men. The mean ejection fraction w
as 39 =/- 15%. Sixty-five had previous myocardial infarction (groupI);
30 (group II) had dilated cardiomyopathy (n=21), right ventricular dy
splasia (n=4), hypertrophic cardiomyopathy (n=2), congenital (n=2) or
valvular (n=1) heart disease. Group III comprised 21 patients with no
apparent cardiac disease or isolated mitral valve prolapse. Brief sync
ope was reported in 12 cases. The paraclinical investigations showed 4
6 patients (66%) with at least two criteria of positivity for ventricu
lar late potentials; Holter recording showed doublets or runs of VES i
n 46% of cases and sustained of non-sustained VT was induced during ex
ercise testing in 16 patients (22%). Programmed ventricular stimulatio
n triggered VT in 85%, 79% and 61% of patients in groups I, II and III
respectively. The patients were treated with amiodarone in 65 cases,
a betablocker in 25 cases, catheter ablation of the origin of the tach
ycardia in 12 cases, antiarrhytmic surgery in 6 cases, coronary bypass
grafting in 5 cases (with an associated anti-arrythmic procedure in 3
cases). An automatic defibrillator was implanted in 9 patients. The a
verage follow-up period was 32 months (range: 17 days to 65 months). T
hirty-two patients died of a cardiac cause including 18 sudden deaths
(56%). The actuarial survival for the whole population was 88 +/- 3% a
t 1 year and 60 +/- 6% at 5 years; this was significantly lower in gro
up I than in group III: 37 +/- 8% versus 92 +/- 7%. Of the factors ana
lysed, low ejection fraction, NYHA stage 2 or more dyspnoea, old age a
nd the presence of atrial fibrillation were prognostic factors for the
risk of death. The presence of ventricular late potentials and the in
ducibility of VT by programmed ventricular stimulation were indicative
of a high risk of recurrence of arrhythmic events: VT, defribrillator
shock and sudden death. These results of patients admitted for VT sho
w a globally poor outcome, related to left ventricular dysfunction. Th
e inducibility of VT by ventricular stimulation and the presence of ve
ntricular late potentials identify a group of patients with a high ris
k of recurrence of a ventricular arrhythmic event.